Table 1 Clinical data of patients included in this study
| Â | Blood samples for ATAC-seq libraries | Blood samples for FACS analysis | Blood samples for CRP stimulation | ||
|---|---|---|---|---|---|
RA patients | OA patients | RA patients | OA patients | OA patients | |
Number of patients | 26 | 23 | 8 | 5 | 8 |
Gender, F/M | 21/5 | 19/4 | 8/0 | 3/2 | 4/4 |
Age (years) | 54 (48–66) | 61 (54–67) | 54.5 (49.5–68.75) | 61 (57–62) | 65 (62–67.75) |
RF positive (%) | 76.9 | 0 | 75 | 0 | 0 |
Anti-CCP positive (%) | 73.1 | NA | 87.5 | NA | NA |
TCJ | 10 (3–12) | NA | 11 (4.75–14) | NA | NA |
SCJ | 10 (4–12) | NA | 10 (3.5–11.5) | NA | NA |
GH | 70 (50–80) | NA | 75 (50–80) | NA | NA |
ESR | 30 (16–42) | 11 (10–14.75) | 29.5 (15.75–46.75) | 14 (8–19) | 8 (6–18.5) |
CRP | 22.9 (6.8–44.3) | 3.13 (3.13–3.14) | 30.22 (6.75–53.95) | 3.11 (3.11–3.12) | 3.055 (2.97–7.3) |
DAS28-ESR | 6 (5–6) | NA | 6 (4.75–7) | NA | NA |
DAS28-CRP | 6 (5–6) | NA | 6 (5.25–6) | NA | NA |